Found: 31
Select item for more details and to access through your institution.
Combination therapy with arsenic trioxide, all‐trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 7, p. 1355, doi. 10.1002/cncr.22524
- By:
- Publication type:
- Article
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: Comparison with historical experience.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 6, p. 1133, doi. 10.1002/cncr.22508
- By:
- Publication type:
- Article
Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaPresented in part at the 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, December 10–13, 2005
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 5, p. 899, doi. 10.1002/cncr.22470
- By:
- Publication type:
- Article
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 2, p. 248
- By:
- Publication type:
- Article
Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 2, p. 265, doi. 10.1002/cncr.22376
- By:
- Publication type:
- Article
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 1, p. 125
- By:
- Publication type:
- Article
Activity of alemtuzumab in patients with CD52‐positive acute leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 12, p. 2645
- By:
- Publication type:
- Article
Thalidomide therapy for myelofibrosis with myeloid metaplasia.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 9, p. 1974
- By:
- Publication type:
- Article
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 7, p. 1569
- By:
- Publication type:
- Article
Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 2, p. 346
- By:
- Publication type:
- Article
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine‐based regimens.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 2, p. 337
- By:
- Publication type:
- Article
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 1, p. 120, doi. 10.1002/cncr.21595
- By:
- Publication type:
- Article
Outcome of patients with acute myelogenous leukemia after second salvage therapy.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 3, p. 547, doi. 10.1002/cncr.21187
- By:
- Publication type:
- Article
2‐Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 3, p. 541, doi. 10.1002/cncr.21186
- By:
- Publication type:
- Article
Interferon α therapy for patients with essential thrombocythemia: Final results of a phase II study initiated in 1986.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 12, p. 2551
- By:
- Publication type:
- Article
Survival benefit with imatinib mesylate therapy in patients with accelerated‐phase chronic myelogenous leukemia—Comparison with historic experience.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 2099
- By:
- Publication type:
- Article
Granulocyte–colony‐stimulating factor (filgrastim) may overcome imatinib‐induced neutropenia in patients with chronic‐phase chronic myelogenous leukemia.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 12, p. 2592
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 7, p. 1449
- By:
- Publication type:
- Article
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 3, p. 581
- By:
- Publication type:
- Article
Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 12, p. 2636
- By:
- Publication type:
- Article
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 9, p. 1905
- By:
- Publication type:
- Article
Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 6, p. 1105, doi. 10.1002/cncr.11629
- By:
- Publication type:
- Article
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosomepositive chronic myelogenous leukemia in early chronic phase.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 5, p. 888
- By:
- Publication type:
- Article
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 3, p. 522
- By:
- Publication type:
- Article
Chronic myelogenous leukemia: A review and update of therapeutic strategies.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 3, p. 437
- By:
- Publication type:
- Article
Treatment of Philadelphia chromosomepositive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside (Dr. Armand Keating served as guest editor for this article.).
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 12, p. 3010
- By:
- Publication type:
- Article
Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders (Dr. Armand Keating served as guest editor on this article.).
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 11, p. 2760
- By:
- Publication type:
- Article
Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 9, p. 2225, doi. 10.1002/cncr.11381
- By:
- Publication type:
- Article
Phase II study of SU5416a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitorin patients with refractory myeloproliferative diseases.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 8, p. 1920
- By:
- Publication type:
- Article
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophagecolony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 7, p. 1711, doi. 10.1002/cncr.11238
- By:
- Publication type:
- Article
Management of patients with systemic mastocytosis: Review of M. D. Anderson Cancer Center experience.
- Published in:
- American Journal of Hematology, 2004, v. 77, n. 3, p. 209, doi. 10.1002/ajh.20211
- By:
- Publication type:
- Article